Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials

Wendy B. London, Rochelle Bagatell, Brenda J. Weigel, Elizabeth Fox, Dongjing Guo, Collin Van Ryn, Arlene Naranjo, Julie R. Park

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint Dive into the research topics of 'Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials'. Together they form a unique fingerprint.

Medicine & Life Sciences